Abstract:Background: According to the ECDC’s latest report, Portugal has the highest incidence of HIV/AIDS and late diagnosis (lymphocyte TCD4+ count <350 cells/μL) in the European Union. Late diagnosis can significantly impact an individual’s health outcomes and the effectiveness of treatment interventions, interfering with overall health outcomes and quality of life. Objectives: Evaluate evolution of HIV diagnosis between 1998-2022 in a district Hospital comparing demographic, epidemiological, AIDS defining illnesses and mortality data. And evaluating the COVD-19 pandemic years regarding the late diagnosis impact, in this matter comparing 2020, 2021 and 2022 with 2017, 2018 and 2019. Methods: Retrospective study of HIV patients (pts) with TCD4+ <350 cells/μL at 1st visit between 1998-2018, divided into group A: TCD4+ <200 cells/ μL; group B: TCD4+ 200-350 cells/μL. Statistical analysis by Excel® from Microsoft 365®, by using the chi-squared test (χ2). Results: From a total of 1175 pts in IDS database, 649 met the criteria but due the lack of data, only 590 were admitted. From these, 63,73% (N=376) in group A and 36,27% (N=214) in B. Demographic and epidemiological characterization revealed (A vs B): male predominance of 79,52% vs 66.82% (p<0,0001); age at diagnosis<50 years 76,59% vs 84,11% (p<0,0001); transmission by heterosexual contact in 53,45% vs 50,93% (p<0,0001). At first health care encounter, 59,84% of group A had an AIDS defining illness-most commonly tuberculosis (33,33%). In a group analysis the percentage of pts in group A raised from 31,4% in 2018 to 32% in 2022. Analysis of mortality showed a death rate of 26,86% in group A versus 16,36% in group B (p<0,0001), with a mean duration from HIV diagnosis to death of 2208 days versus 2940 (p<0,0001). On average, time from first Infectious Diseases (ID) consultation to death was 1441 days in group A and 2308 in group B (p<0,0001). Analyzing before (2017-2019) and during COVID-19 (2020-2022), the prevalence of late presenters (<350 TCD4+/μl) went from 3.90% to 8.81% globally; an increase of 55.77% (23 to 52 pts), maintaining proportion of genders. During COVID-19 an increase in overall mortality was observed 26.86% vs 16.36% (group A vs B pre-pandemic) to 28.86% vs 18.92% (group A vs B pandemic) not due COVID infection. Conclusion: This study highlights the persistent challenge of late HIV diagnosis and its profound impact on patient outcomes. The demographic and epidemiological characterization underscores the need for targeted interventions to address disparities in testing and care access. The observed increase in late presenters and mortality rates during the COVID-19 pandemic underscores the importance of maintaining HIV care services amidst public health crises. Timely diagnosis, early intervention, and comprehensive care remain imperative to improve outcomes and advance towards the goal of ending AIDS as a public health threat by 2030.

Is it possible to control HIV infection in a middle-income country through a multidisciplinary approach?

Human immunodeficiency virus cascade-continuum of care stages and outcomes in a hospital in southern Brazil

Structured intermittent therapy with seven-day cycles of HAART for chronic HIV infection: a pilot study in São Paulo, Brazil

Antiretroviral treatment, government policy and economy of HIV/AIDS in Brazil: is it time for HIV cure in the country?

Long-term immune and virological response in HIV-infected patients receiving antiretroviral therapy

Improving the continuum of care monitoring in Brazilian HIV healthcare services: An implementation science approach

Matching Social Support to Individual Needs: A Community-Based Intervention to Improve HIV Treatment Adherence in a Resource-Poor Setting

Late Diagnosis in HIV: Experience of a Portuguese District Hospital between 1998-2022 (Too Late Study)

Evaluation of oral care protocols practice by dentists in Rio de Janeiro towards HIV/AIDS individuals

Rapid CD4 cell count determination and Cryptococcus and Histoplasma antigen detection in people living with HIV: Implementation of a package of care strategy in a pilot study, Argentina

New forms of citizenship and socio-political inclusion: accessing antiretroviral therapy in a Rio de Janeiro favela

Healthcare Providers' Perspectives on a Novel Couple-Based HIV Treatment Intervention: A Qualitative Assessment of the Facilitators, Barriers, and Proposed Improvements to Implementation in Zambézia Province, Mozambique

AIDS Treatment In Brazil: Impacts And Challenges

Reducing intersectional stigma among transgender women in Brazil to promote uptake of HIV testing and PrEP: study protocol for a randomised controlled trial of Manas por Manas

Barriers and facilitators for men to attend prenatal care and obtain HIV voluntary counseling and testing in Brazil

Cluster-Based Multinomial Logistic Regression Model for Health-Related Quality of Life Among People Living with HIV in Brazil

Strengthening HIV and HIV co-morbidity care in low- and middle-income countries: insights from behavioural economics to improve healthcare worker behaviour

“If you are here at the clinic, you do not know how many people need help in the community”: Perspectives of home-based HIV services from health care workers in rural KwaZulu-Natal, South Africa in the era of universal test-and-treat

Partner-based HIV treatment for seroconcordant couples attending antenatal and postnatal care in rural Mozambique: A cluster randomized controlled trial

Sociobehavioral Risk Factors and Clinical Implications of Late Presentation Among People Living with HIV in the Brazilian Amazon Region

Dynamics and features of transmission clusters of HIV-1 subtypes in the state of São Paulo, Brazil